Levodopa/benserazide
Combination of
LevodopaDopamine agonist
BenserazideDecarboxylase inhibitors
Clinical data
Trade namesProlopa, Madopar, others[1]
Pregnancy
category
Routes of
administration		By mouth
ATC code
Legal status
Legal status
Identifiers
KEGG

Levodopa/benserazide, sold under the brand name Prolopa among others, is a fixed-dose combination medication used for the treatment of Parkinson's disease.[2][3][4]

Medical uses

Levodopa/benserazide is indicated for the treatment of Parkinson's disease with the exception of drug-induced parkinsonism.[2][3][4]

References

  1. ^ "Levodopa".
  2. ^ a b c d https://www.guildlink.com.au/gc/ws/ro/pi.cfm?product=ropmadop10710
  3. ^ a b c "Prolopa Product information". Health Canada. 25 April 2012. Retrieved 8 January 2023.
  4. ^ a b c "Madopar 100 mg/25 mg Dispersible Tablets - Summary of Product Characteristics (SmPC)". (emc). 8 April 2020. Retrieved 9 January 2023.

External links


Antiparkinson agents (N04)
Monoamine metabolism modulators
More
Categories